These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20725)

  • 1. [Study of the binding of beta blockers to plasma proteins. Therapeutic consequences].
    Decourt S; Roux A; Baglin A; Domart M; Aubert P; Flouvat B; Fritel D
    Acquis Med Recent; 1977; ():181-94. PubMed ID: 20725
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the beta-adrenergic blockers propranolol and acebutolol on stress-induced learned helplessness behavior of rats.
    Danchev N; Staneva-Stoytcheva D
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):463-7. PubMed ID: 8577208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of beta-blockers on plasma renin activity. Present status].
    Plouin PF; Ménard J; Corvol P; Milliez P
    Nouv Presse Med; 1978 Sep; 7(31):2769-74. PubMed ID: 30961
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-blocking potency and electrophysiologic effects of acebutolol.
    Singh BN; Williams R; Harrison DC
    Am Heart J; 1985 May; 109(5 Pt 2):1126-31. PubMed ID: 2859775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile haemangioma and β-blockers in otolaryngology.
    Leboulanger N; Cox A; Garabedian EN; Denoyelle F
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):236-40. PubMed ID: 21498145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective binding of beta-blockers to purified rat alpha 1-acid glycoprotein.
    Murai-Kushiya M; Okada S; Kimura T; Hasegawa R
    J Pharm Pharmacol; 1993 Mar; 45(3):225-8. PubMed ID: 8097783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertensive heart. Experience in the clinical use of sectral (acebutolol)].
    Kardiologiia; 1992; 32(11-12):85-98. PubMed ID: 1363671
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment by beta-blockers of arterial hypertension in patients with chronic renal insufficiency on hemodialysis].
    Fillastre JP; Godin M
    Nouv Presse Med; 1978 Sep; 7(31):2799-801. PubMed ID: 30968
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
    Whitsett TL; Levin DC; Manion CV
    Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [beta-blockers in hypertension with renal failure].
    Guédon J; Aubert P; Lucsko M; Chaignon M
    Nouv Presse Med; 1978 Sep; 7(31):2795-7. PubMed ID: 30967
    [No Abstract]   [Full Text] [Related]  

  • 12. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac effects of beta-adrenergic receptor antagonists: beta-moderators versus beta-blockers.
    Dhalla NS; Alto LE; Pierce GN; Daly MJ; Dhillon KS; Compier R; Guerin A
    Clin Ther; 1980; 3(4):254-9. PubMed ID: 6115715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
    Giorgis GE; Galietti F; Miravalle C; Barberis S; Massaglia GM; Onoscuri E
    Minerva Med; 1986 Jun; 77(26):1255-8. PubMed ID: 2873530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)).
    van Steeg TJ; Krekels EH; Freijer J; Danhof M; de Lange EC
    J Pharm Sci; 2010 May; 99(5):2511-20. PubMed ID: 20020526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of beta-blockers in human plasma using liquid chromatography-tandem mass spectrometry.
    Umezawa H; Lee XP; Arima Y; Hasegawa C; Izawa H; Kumazawa T; Sato K
    Biomed Chromatogr; 2008 Jul; 22(7):702-11. PubMed ID: 18318013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of protein binding on dialysis clearance of several beta-blocking agents in chronically hemodialysed patients].
    Decourt S; Roux A; Baglin A; Aubert P; Prinseau J; Flouvat B
    Therapie; 1982; 37(6):635-40. PubMed ID: 6132462
    [No Abstract]   [Full Text] [Related]  

  • 18. Acebutolol: ten years of experience.
    De Bono G; Kaye CM; Roland E; Summers AJ
    Am Heart J; 1985 May; 109(5 Pt 2):1211-3. PubMed ID: 2859785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol increases the threshold for lidocaine-induced convulsions in awake rats: a direct effect on the brain.
    Nakamura T; Oda Y; Takahashi R; Tanaka K; Hase I; Asada A
    Anesth Analg; 2008 May; 106(5):1450-5, table of contents. PubMed ID: 18420859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxicologic analysis of some adrenergic-beta blockers in the diagnosis of intoxications].
    Wachowiak R; Tezyk A
    Arch Med Sadowej Kryminol; 2003; 53(4):289-99. PubMed ID: 14971294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.